Showing results (11-20 of 443) with videos related to

Sort By:
Pageof 45
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2007
Outcomes among patients with recurrent high-risk hematologic malignancies after allogeneic hematopoietic cell transplantationMarco Mielcarek, Barry E Storer, Mary E D Flowers, et al.
Blood|July 5, 2005
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCTMohamed L Sorror, Michael B Maris, Rainer Storb, et al.
Transplantation|August 19, 2003
Dog leukocyte antigen nonidentical unrelated canine marrow grafts: enhancement of engraftment by CD4 and CD8 T cellsJens P Panse, Carla Bastianelli, Erlinda B Santos, et al.
Transplantation and Cellular Therapy|March 29, 2021
Addition of Astatine-211-Labeled Anti-CD45 Antibody to TBI as Conditioning for DLA-Identical Marrow Transplantation: A Novel Strategy to Overcome Graft Rejection in a Canine Presensitization Model: "Radioimmunotherapy to Overcome Transfusion-Induced Sensitization"Aya Nakaya, Huiying Qiu, Erlinda B Santos, et al.
Haematologica|September 2, 2011
Cytopenias after day 28 in allogeneic hematopoietic cell transplantation: impact of recipient/donor factors, transplant conditions and myelotoxic drugsHirohisa Nakamae, Barry Storer, Brenda M Sandmaier, et al.
Transplantation|July 14, 2010
Evaluation of posttransplant methotrexate to facilitate engraftment in the canine major histocompatibility complex-haploidentical nonmyeloablative transplant modelMonica S Thakar, Erlinda B Santos, Theodore A Gooley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2020
Impact of Rituximab and Host/Donor Fc Receptor Polymorphisms after Allogeneic Hematopoietic Cell Transplantation for CD20<sup>+</sup> B Cell MalignanciesNoa Granot, Andrew R Rezvani, Barbara S Pender, et al.
Bone Marrow Transplantation|April 26, 2025
Subsequent cancers following non-myeloablative conditioning for allogeneic hematopoietic cell transplantationPhuong Vo, Kevin Ng, Gary Schoch, et al.
Blood|April 29, 2004
Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbiditiesMohamed L Sorror, Michael B Maris, Barry Storer, et al.
Transplantation|August 19, 2004
Radioimmunotherapy with bismuth-213 as conditioning for nonmyeloablative allogeneic hematopoietic cell transplantation in dogs: a dose deescalation studyWolfgang A Bethge, D Scott Wilbur, Rainer Storb, et al.
Pageof 45